Oaktree Acquisition Corp. III Life Sciences (OACCU) Stock Price, News & Analysis

Company Overview

We are a newly organized blank check company incorporated on June 28, 2024, as a Cayman Islands exempted company formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses, which we refer to throughout this prospectus as our initial business combination. To date, our efforts have been limited to organizational activities as well as activities related to this offering. We have not selected any specific business combination target and we have not, nor has anyone on our behalf, initiated any substantive discussions, directly or indirectly, with any business combination target. We have generated no operating revenues to date and we do not expect that we will generate operating revenues until we consummate our initial business combination. While we may pursue an acquisition opportunity in any business, industry, sector, or geographical location, we intend to focus on industries that complement our management team’s background, and to capitalize on the ability of our management team to identify and acquire a business, focusing on the healthcare or healthcare-related industries. In particular, we intend to target North American, British or European companies in the biopharmaceutical, medical devices, diagnostics, and specialized healthcare services sectors where our management has extensive investment experience. Our executive offices are located at 333 South Grand Avenue, 28th Floor, Los Angeles, California 90071.

Key Stats

• Today's Range: $10.17 to $10.19
• 50-Day Range: $10.06 to $10.22
• 52-Week Range: $9.99 to $10.22
• Volume: 2,000 shs
• Average Volume: 2,955 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

OACCU Stock Analysis - Frequently Asked Questions

How have OACCU shares performed this year?

Oaktree Acquisition Corp. III Life Sciences' stock was trading at $10.13 on January 1st, 2025. Since then, OACCU shares have increased by 0.2% and is now trading at $10.15.
View the best growth stocks for 2025 here.

When did Oaktree Acquisition Corp. III Life Sciences IPO?

Oaktree Acquisition Corp. III Life Sciences (OACCU) raised $175 million in an initial public offering (IPO) on Thursday, October 24th 2024. The company issued 17,500,000 shares at a price of $10.00 per share. Jefferies, Citigroup and UBS Investment Bank acted as the underwriters for the IPO.

When did Oaktree Acquisition Corp. III Life Sciences' quiet period expire?

Oaktree Acquisition Corp. III Life Sciences' quiet period expired on Tuesday, December 3rd. Oaktree Acquisition Corp. III Life Sciences had issued 17,500,000 shares in its IPO on October 24th. The total size of the offering was $175,000,000 based on an initial share price of $10.00. During Oaktree Acquisition Corp. III Life Sciences' quiet period, underwriters and any insiders involved in the IPO were prevented from issuing any research reports or earnings estimates for the company because of SEC regulations. Now that the company's quiet period has ended, brokerages that served as underwriters are now able to initiate research on the company.

How do I buy shares of Oaktree Acquisition Corp. III Life Sciences?

Shares of OACCU stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Finance, Insurance, And Real Estate
• Industry: Investment Offices
• Sub-Industry: Trading
• Current Symbol: NASDAQ:OACCU
• CUSIP: N/A
• CIK: 2029769
• Web: N/A
• Phone: (213) 830-6300
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: N/A
• Beta: N/A